Most a short while ago, it's been recognized that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in comparable locations as classical opioid receptors, it binds to a big range of endogenous opioids. As opposed to most opioid receptors, this receptor functions being a scavenger and isn't